Search Results - "Gordon, Lynn"

Refine Results
  1. 1
  2. 2

    Gender-based differences in letters of recommendation written for ophthalmology residency applicants by Lin, Fei, Oh, Soo Kyung, Gordon, Lynn K, Pineles, Stacy L, Rosenberg, Jamie B, Tsui, Irena

    Published in BMC medical education (30-12-2019)
    “…To determine whether gender-based differences may be present in letters of recommendation written for ophthalmology residency applicants. All applications…”
    Get full text
    Journal Article
  3. 3

    Women’s Representation Among Members and Leaders of National Medical Specialty Societies by Jagsi, Reshma, Means, Olivia, Lautenberger, Diana, Jones, Rochelle D, Griffith, Kent A, Flotte, Terence R, Gordon, Lynn K, Rexrode, Kathryn M, Wagner, Lori W, Chatterjee, Archana

    Published in Academic medicine (01-07-2020)
    “…PURPOSENational medical specialty societies speak for their respective fields in policy debates, influence research, affect trainees’ specialization decisions,…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Enhancing Diversity in the Ophthalmology Workforce by Woreta, Fasika A, Gordon, Lynn K, Knight, O'Rese J, Randolph, Jessica D, Zebardast, Nazlee, Pérez-González, César E

    Published in Ophthalmology (Rochester, Minn.) (01-10-2022)
    “…Health care teams are most effective at addressing complex problems and improving health outcomes for underserved populations when team members bring diverse…”
    Get full text
    Journal Article
  6. 6

    An Eye on Gender Equality: A Review of the Evolving Role and Representation of Women in Ophthalmology by Gill, Hannah K., Niederer, Rachael L., Shriver, Erin M., Gordon, Lynn K., Coleman, Anne L., Danesh-Meyer, Helen V.

    Published in American journal of ophthalmology (01-04-2022)
    “…In recent decades, women have achieved greater representation in ophthalmology. Globally, women now constitute approximately 25%-30% of ophthalmologists and…”
    Get full text
    Journal Article
  7. 7

    Neuro-Ophthalmic Manifestations of HIV Infection by Gordon, Lynn K., Danesh-Meyer, Helen

    Published in Ocular immunology and inflammation (02-10-2020)
    “…Purpose: To review the broad spectrum of clinical neuro-ophthalmic presentations associated with human immunodeficiency virus (HIV) infection. Methods:…”
    Get full text
    Journal Article
  8. 8

    It Is Time for Zero Tolerance for Sexual Harassment in Academic Medicine by Bates, Carol K., Jagsi, Reshma, Gordon, Lynn K., Travis, Elizabeth, Chatterjee, Archana, Gillis, Marin, Means, Olivia, Chaudron, Linda, Ganetzky, Rebecca, Gulati, Martha, Fivush, Barbara, Sharma, Poonam, Grover, Amelia, Lautenberger, Diana, Flotte, Terence R.

    Published in Academic medicine (01-02-2018)
    “…While more women are in leadership positions in academic medicine now than ever before in U.S. history, evidence from recent surveys of women and graduating…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Paraneoplastic Syndromes in Neuro-Ophthalmology by Gordon, Lynn K

    Published in Journal of neuro-ophthalmology (01-09-2015)
    “…BACKGROUND:Paraneoplastic syndromes that affect the visual pathways and present with neuro-ophthalmologic signs or symptoms may involve the afferent or…”
    Get full text
    Journal Article
  13. 13

    Uveitis in Patients Treated with CTLA-4 and PD-1 Checkpoint Blockade Inhibition by Sun, Michel M., Levinson, Ralph D., Filipowicz, Artur, Anesi, Stephen, Kaplan, Henry J., Wang, Wei, Goldstein, Debra A., Gangaputra, Sapna, Swan, Robert T., Sen, H. Nida, Gordon, Lynn K.

    Published in Ocular immunology and inflammation (17-02-2020)
    “…Purpose: To investigate the link between treatment with CTLA-4 and PD-1 checkpoint blockade inhibitors and the development of noninfectious uveitis. Methods: A…”
    Get full text
    Journal Article
  14. 14

    Clinical Utility of Antiretinal Antibody Testing by Chen, John J, McKeon, Andrew, Greenwood, Tammy M, Flanagan, Eoin P, Bhatti, M Tariq, Dubey, Divyanshu, Pulido, Jose S, Iezzi, Raymond, Smith, Wendy M, Sen, H Nida, Gordon, Lynn K, Pittock, Sean J

    Published in JAMA ophthalmology (01-06-2021)
    “…The clinical utility of most antiretinal antibodies (retina antibodies) currently available for testing remains unclear and unproven. Despite this, the…”
    Get more information
    Journal Article
  15. 15

    Population-Based Frequency of Ophthalmic Adverse Events in Melanoma, Other Cancers, and After Immune Checkpoint Inhibitor Treatment by Braun, David, Getahun, Darios, Chiu, Vicki Y., Coleman, Anne L., Holland, Gary N., Yu, Fei, Gordon, Lynn K., Sun, Michel M.

    Published in American journal of ophthalmology (01-04-2021)
    “…To examine the frequency of ophthalmic immune-related adverse events (OirAEs) in melanoma, other cancers, and after immune checkpoint inhibitor (ICI)…”
    Get full text
    Journal Article
  16. 16

    89Zr-ImmunoPET for the Specific Detection of EMP2-Positive Tumors by Chan, Ann M, Olafsen, Tove, Tsui, Jessica, Salazar, Felix B, Aguirre, Brian, Zettlitz, Kirstin A, Condro, Michael, Wu, Anna M, Braun, Jonathan, Gordon, Lynn K, Ashki, Negin, Whitelegge, Julian, Xu, Shili, Ikotun, Oluwatayo, Lee, Jason Thanh, Wadehra, Madhuri

    Published in Molecular cancer therapeutics (04-06-2024)
    “…Epithelial membrane protein-2 (EMP2) is upregulated in a number of tumors and therefore remains a promising target for mAb-based therapy. In the current study,…”
    Get more information
    Journal Article
  17. 17

    Epithelial membrane protein 2 (EMP2) regulates hypoxia-induced angiogenesis in the adult retinal pigment epithelial cell lines by Sun, Michel, Cherian, Nina, Liu, Lucia, Chan, Ann M., Aguirre, Brian, Chu, Alison, Strawbridge, Jason, Kim, Esther S., Lin, Meng-Chin, Tsui, Irena, Gordon, Lynn K., Wadehra, Madhuri

    Published in Scientific reports (12-11-2022)
    “…Pathologic retinal neovascularization is a potentially blinding consequence seen in many common diseases including diabetic retinopathy, retinopathy of…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Mesenchymal stem cell population derived from human pluripotent stem cells displays potent immunomodulatory and therapeutic properties by Kimbrel, Erin A, Kouris, Nicholas A, Yavanian, Gregory J, Chu, Jianlin, Qin, Yu, Chan, Ann, Singh, Ram P, McCurdy, Deborah, Gordon, Lynn, Levinson, Ralph D, Lanza, Robert

    Published in Stem cells and development (15-07-2014)
    “…Mesenchymal stem cells (MSCs) are being tested in a wide range of human diseases; however, loss of potency and inconsistent quality severely limit their use…”
    Get more information
    Journal Article